vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与TSS, Inc.（TSSI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是TSS, Inc.的1.2倍（$75.5M vs $60.9M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 21.8%），TSS, Inc.自由现金流更多（$15.8M vs $14.4M），过去两年TSS, Inc.的营收复合增速更高（95.8% vs 31.3%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
PBYI vs TSSI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$60.9M
营收增速更快
PBYI
高出6.0%
21.8%
自由现金流更多
TSSI
多$1.4M
$14.4M
两年增速更快
TSSI
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $60.9M |
| 净利润 | — | $12.2M |
| 毛利率 | 69.3% | 17.6% |
| 营业利润率 | 22.7% | 1.5% |
| 净利率 | — | 20.0% |
| 营收同比 | 27.7% | 21.8% |
| 净利润同比 | — | 535.7% |
| 每股收益（稀释后） | $0.26 | $0.44 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYITSSI
| Q4 25 | $75.5M | $60.9M | ||
| Q3 25 | $54.5M | $41.9M | ||
| Q2 25 | $52.4M | $44.0M | ||
| Q1 25 | $46.0M | $99.0M | ||
| Q4 24 | $59.1M | $50.0M | ||
| Q3 24 | $80.5M | $70.1M | ||
| Q2 24 | $47.1M | $12.2M | ||
| Q1 24 | $43.8M | $15.9M |
净利润PBYITSSI
| Q4 25 | — | $12.2M | ||
| Q3 25 | $8.8M | $-1.5M | ||
| Q2 25 | $5.9M | $1.5M | ||
| Q1 25 | $3.0M | $3.0M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | $20.3M | $2.6M | ||
| Q2 24 | $-4.5M | $1.4M | ||
| Q1 24 | $-4.8M | $15.0K |
毛利率PBYITSSI
| Q4 25 | 69.3% | 17.6% | ||
| Q3 25 | 77.7% | 11.1% | ||
| Q2 25 | 76.5% | 17.8% | ||
| Q1 25 | 77.1% | 9.3% | ||
| Q4 24 | 76.4% | 14.4% | ||
| Q3 24 | 63.9% | 11.3% | ||
| Q2 24 | 77.4% | 37.3% | ||
| Q1 24 | 75.5% | 17.1% |
营业利润率PBYITSSI
| Q4 25 | 22.7% | 1.5% | ||
| Q3 25 | 17.6% | -2.2% | ||
| Q2 25 | 12.7% | 5.1% | ||
| Q1 25 | 8.7% | 4.2% | ||
| Q4 24 | 22.6% | 0.0% | ||
| Q3 24 | 27.4% | 5.4% | ||
| Q2 24 | -4.6% | 14.0% | ||
| Q1 24 | -5.3% | 1.6% |
净利率PBYITSSI
| Q4 25 | — | 20.0% | ||
| Q3 25 | 16.2% | -3.6% | ||
| Q2 25 | 11.2% | 3.4% | ||
| Q1 25 | 6.5% | 3.0% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | 25.2% | 3.8% | ||
| Q2 24 | -9.6% | 11.5% | ||
| Q1 24 | -11.0% | 0.1% |
每股收益（稀释后）PBYITSSI
| Q4 25 | $0.26 | $0.44 | ||
| Q3 25 | $0.17 | $-0.06 | ||
| Q2 25 | $0.12 | $0.06 | ||
| Q1 25 | $0.06 | $0.12 | ||
| Q4 24 | $0.40 | $0.08 | ||
| Q3 24 | $0.41 | $0.10 | ||
| Q2 24 | $-0.09 | $0.06 | ||
| Q1 24 | $-0.10 | $0.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $85.5M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $76.6M |
| 总资产 | $216.3M | $184.9M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYITSSI
| Q4 25 | $97.5M | $85.5M | ||
| Q3 25 | $94.4M | $70.7M | ||
| Q2 25 | $96.0M | — | ||
| Q1 25 | $93.2M | — | ||
| Q4 24 | $101.0M | $23.2M | ||
| Q3 24 | $96.7M | $46.4M | ||
| Q2 24 | $96.8M | $8.3M | ||
| Q1 24 | $107.2M | $14.4M |
总债务PBYITSSI
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYITSSI
| Q4 25 | $130.3M | $76.6M | ||
| Q3 25 | $115.3M | $63.4M | ||
| Q2 25 | $104.7M | $9.5M | ||
| Q1 25 | $97.1M | $9.4M | ||
| Q4 24 | $92.1M | $7.1M | ||
| Q3 24 | $71.1M | $7.7M | ||
| Q2 24 | $48.5M | $5.2M | ||
| Q1 24 | $51.0M | $3.7M |
总资产PBYITSSI
| Q4 25 | $216.3M | $184.9M | ||
| Q3 25 | $202.9M | $165.4M | ||
| Q2 25 | $194.9M | $139.5M | ||
| Q1 25 | $196.2M | $113.5M | ||
| Q4 24 | $213.3M | $96.6M | ||
| Q3 24 | $220.7M | $67.3M | ||
| Q2 24 | $205.0M | $28.9M | ||
| Q1 24 | $214.1M | $26.8M |
负债/权益比PBYITSSI
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $16.3M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $15.8M |
| 自由现金流率自由现金流/营收 | 19.1% | 25.9% |
| 资本支出强度资本支出/营收 | 0.0% | 0.9% |
| 现金转化率经营现金流/净利润 | — | 1.34× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $2.1M |
8季度趋势，按日历期对齐
经营现金流PBYITSSI
| Q4 25 | $14.4M | $16.3M | ||
| Q3 25 | $9.7M | $-18.4M | ||
| Q2 25 | $14.1M | $16.3M | ||
| Q1 25 | $3.6M | $20.6M | ||
| Q4 24 | $15.6M | $-21.6M | ||
| Q3 24 | $11.0M | $38.6M | ||
| Q2 24 | $1.0M | $-4.3M | ||
| Q1 24 | $11.2M | $2.6M |
自由现金流PBYITSSI
| Q4 25 | $14.4M | $15.8M | ||
| Q3 25 | $9.7M | $-24.9M | ||
| Q2 25 | $14.1M | $5.4M | ||
| Q1 25 | $3.6M | $5.8M | ||
| Q4 24 | $15.6M | $-28.4M | ||
| Q3 24 | $11.0M | $38.6M | ||
| Q2 24 | $1.0M | $-6.0M | ||
| Q1 24 | — | $2.6M |
自由现金流率PBYITSSI
| Q4 25 | 19.1% | 25.9% | ||
| Q3 25 | 17.7% | -59.3% | ||
| Q2 25 | 26.8% | 12.3% | ||
| Q1 25 | 7.7% | 5.8% | ||
| Q4 24 | 26.4% | -56.7% | ||
| Q3 24 | 13.7% | 55.1% | ||
| Q2 24 | 2.1% | -49.4% | ||
| Q1 24 | — | 16.4% |
资本支出强度PBYITSSI
| Q4 25 | 0.0% | 0.9% | ||
| Q3 25 | 0.0% | 15.3% | ||
| Q2 25 | 0.0% | 24.8% | ||
| Q1 25 | 0.1% | 15.0% | ||
| Q4 24 | 0.0% | 13.4% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | 0.0% | 13.8% | ||
| Q1 24 | 0.0% | 0.2% |
现金转化率PBYITSSI
| Q4 25 | — | 1.34× | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | 11.02× | ||
| Q1 25 | 1.21× | 6.93× | ||
| Q4 24 | — | -11.32× | ||
| Q3 24 | 0.54× | 14.60× | ||
| Q2 24 | — | -3.09× | ||
| Q1 24 | — | 176.40× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
TSSI
| Procurement Revenues Segment | $43.2M | 71% |
| System Integration Services Segment | $14.2M | 23% |
| Facilities Segment | $3.5M | 6% |
